Aurora Cannabis (ACB)

Company Profile

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Company profile

Ticker

ACB

Exchange

NASDAQ

Website

www.auroramj.com

CEO

Mr. Miguel Martin

Incorporated

Delaware

Location

New York

Fiscal year end

Mar 31

Industry (SIC)

Surgical & Medical Instruments & Apparatus

GE Vernova • AXIS Capital Holdings Limited • Ares Capital • Liberty Latin America • Royalty Pharma • Ashland • Zimmer Biomet • GFL Environmental • Conduent • MultiPlan ...

Former names

AIT Therapeutics, Inc., KokiCare, Inc.

SEC CIK

0001683541

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

ACB stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

6-K

Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

6 Nov 24

6-K

Condensed Consolidated Interim Financial Statements

6 Nov 24

6-K

Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call

24 Oct 24

S-8

Registration of securities for employees

20 Sep 24

6-K

Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

20 Sep 24

6-K

Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence

17 Sep 24

6-K

Material Change Report

26 Aug 24

6-K

Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

12 Aug 24

6-K

Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow

7 Aug 24

6-K

Condensed Consolidated Interim Financial Statements

7 Aug 24

Transcripts

View all

ACB

Earnings call transcript

2023 Q1

11 Nov 22

ACB

Earnings call transcript

2022 Q4

21 Sep 22

ACB

Earnings call transcript

2022 Q3

13 May 22

ACB

Earnings call transcript

2022 Q2

11 Feb 22

ACB

Earnings call transcript

2021 Q1

10 Nov 21

ACB

Earnings call transcript

2021 Q4

28 Sep 21

ACB

Earnings call transcript

2021 Q3

14 May 21

ACB

Earnings call transcript

2021 Q2

12 Feb 21

ACB

Earnings call transcript

2021 Q1

9 Nov 20

Latest ownership filings

SC 13G/A

CVI Investments, Inc.

14 Feb 23

SC 13G

CVI Investments, Inc.

1 Jun 22

SC 13G/A

ETF MANAGERS GROUP, LLC

14 Feb 22

SC 13G/A

ETF MANAGERS GROUP, LLC

1 Jun 21

SC 13G/A

ETF MANAGERS GROUP, LLC

28 Jan 21

SC 13G

ETF MANAGERS GROUP, LLC

8 Jan 21

Financial summary

Financial statements Chart ACB financial data

Quarter (USD)	Mar 24	Mar 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Mar 24	Mar 23	Jun 22	Jun 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

ACB institutional ownership history Ownership history

35.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	165	162	+1.9%
Opened positions	29	66	-56.1%
Closed positions	26	64	-59.4%
Increased positions	29	5	+480.0%
Reduced positions	22	89	-75.3%

13F shares	Current	Prev Q	Change
Total value	16.30 bn	9.82 bn	+65.9%
Total shares	19.44 mm	21.32 mm	-8.9%
Total puts	2.72 mm	2.36 mm	+14.9%
Total calls	3.19 mm	2.41 mm	+32.4%
Total put/call ratio	0.9	1.0	-13.2%

Largest owners	Shares	Value	Change
CVI Investments	15.78 mm	$0.00	0.0%
Toroso Investments	1.31 mm	$6.05 bn	NEW
Renaissance Technologies	616.76 k	$2.85 bn	-29.9%
MS Morgan Stanley	169.09 k	$781.21 mm	+33.1%
Centiva Capital	123.99 k	$572.81 mm	+223.4%
Jane Street	120.57 k	$557.01 mm	-14.5%
Susquehanna International	114.73 k	$530.05 mm	-75.5%
GS The Goldman Sachs Group, Inc.	97.86 k	$452.12 mm	NEW
Millennium Management	95.81 k	$442.55 mm	+4.0%
Dimensional Fund Advisors	86.29 k	$398.65 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Mirae Asset Global Investments	0.00	-2.30 mm	EXIT
Toroso Investments	1.31 mm	+1.31 mm	NEW
Susquehanna International	114.73 k	-353.18 k	-75.5%
Renaissance Technologies	616.76 k	-262.92 k	-29.9%
HRT Financial	0.00	-182.85 k	EXIT
Virtu Financial	15.57 k	-150.14 k	-90.6%
Parallax Volatility Advisers	15.66 k	-114.87 k	-88.0%
GS The Goldman Sachs Group, Inc.	97.86 k	+97.86 k	NEW
Centiva Capital	123.99 k	+85.65 k	+223.4%
Group One Trading	69.30 k	+69.30 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.